Annie Yoshiyama

Insider Reports History

Location
South San Francisco, CA
Signature
/s/Earl Douglas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Annie Yoshiyama:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. SVP, Finance Common Stock 130,322 $224,153 $1.72 02 Feb 2026 Direct
Allogene Therapeutics, Inc. SVP, Finance Stock Option (Right to buy) 179,691 02 Feb 2026 Direct
Allogene Therapeutics, Inc. SVP, Finance Restricted Stock Unit 50,827 02 Feb 2026 Direct
Tricida, Inc. Senior VP, Finance and CAO Employee Stock Option (right to buy) 14,000 05 Aug 2022 Direct

Insider Reports Filed by Annie Yoshiyama

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALLO Allogene Therapeutics, Inc. 02 Feb 2026 3 -$7,167 4 SVP, Finance 04 Feb 2026, 17:09
ALLO Allogene Therapeutics, Inc. 21 Apr 2025 1 -$13,537 4 SVP, Finance 23 Apr 2025, 17:28
ALLO Allogene Therapeutics, Inc. 24 Jan 2025 2 $0 4 SVP, Finance 28 Jan 2025, 20:14
ALLO Allogene Therapeutics, Inc. 05 Jun 2024 0 $0 3 SVP, Finance 11 Jun 2024, 16:10
/report/000159558522000069-yoshiyama-annie-2022-08-05 Tricida, Inc. 05 Aug 2022 1 $0 4 Senior VP, Finance and CAO 09 Aug 2022, 16:22
/report/000159558522000018-yoshiyama-annie-2022-02-28 Tricida, Inc. 28 Feb 2022 1 $0 4 VP, Finance and CAO 02 Mar 2022, 15:55
/report/000159558521000109-yoshiyama-annie-2021-08-16 Tricida, Inc. 16 Aug 2021 11 $0 4 VP, Finance and CAO 18 Aug 2021, 16:11